Acetylcysteine

Nisha Patel, PharmD, MBA, BCPS, Alona Crowder, Pharm.D.
Acetylcysteine is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Adjuvant mucolytic therapy for patients with abnormal, viscid, or inspissated mucous secretions secondary to respiratory diseases such as emphysema, tuberculosis, bronchitis or for treatment of respiratory complications of cystic fibrosis and tracheostomy care.

NON-FDA APPROVED USES

  • Nephrotoxicity prophylaxis (focus of this module)
  • Acetaminophen overdose

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Adjuvant mucolytic therapy for patients with abnormal, viscid, or inspissated mucous secretions secondary to respiratory diseases such as emphysema, tuberculosis, bronchitis or for treatment of respiratory complications of cystic fibrosis and tracheostomy care.

NON-FDA APPROVED USES

  • Nephrotoxicity prophylaxis (focus of this module)
  • Acetaminophen overdose

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: July 3, 2020